Analyst Reco. Legend Biotech Corporation

Equities

LEGN

US52490G1022

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 08/05/2026 BST			5-day change	1st Jan Change
28.12 ^USD	-1.58%		+19.20%	+29.35%

04-24	Eqt X Usd Scsp and Eqt X Eur Scsp, managed by Eqt Fund Management S.à R.L cancelled the acquisition of Intertek Group plc.	CI
04-14	Genscript Biotech Associate Logs $597 Million in Q1 Sales of Carvykti	MT

Analyst Reco.

03-11	Legend Biotech Shares Likely to Rebound in 2026 on Robust Fundamentals, RBC Says	MT
03-11	RBC Cuts Price Target on Legend Biotech to $62 From $66, Keeps Outperform Rating	MT
02-12	Legend Biotech Shares Lower After Rothschild & Co Redburn Downgrade	MT
02-12	Rothschild & Co Redburn Downgrades Legend Biotech to Neutral From Buy	MT
01-22	TD Cowen Downgrades Legend Biotech to Hold From Buy, Adjusts Price Target to $21 From $62	MT
01-08	RBC Cuts Price Target on Legend Biotech to $66 From $74, Keeps Outperform Rating	MT
01-07	Oppenheimer Initiates Legend Biotech at Outperform With $75 Price Target	MT
12-10	Legend Biotech's Stock Weakness After Rival Treatment Update 'Overdone,' RBC Says	MT
12-08	UBS Adjusts Legend Biotech Price Target to $48 From $54, Maintains Buy Rating	MT
11-13	RBC Trims Price Target on Legend Biotech to $74 From $75, Keeps Outperform Rating	MT
11-13	Truist Lowers Price Target on Legend Biotech to $70 From $71, Keeps Buy Rating	MT
08/10/25	RBC Trims Price Target on Legend Biotech to $75 From $77, Keeps Outperform Rating	MT
12/08/25	RBC Capital Adjusts Price Target on Legend Biotech to $77 From $75, Maintains Outperform Rating	MT
07/07/25	RBC Lowers Price Target on Legend Biotech to $75 From $78, Keeps Outperform Rating	MT
03/07/25	UBS Lowers Price Target on Legend Biotech to $54 From $60, Maintains Buy Rating	MT
14/05/25	Truist Securities Adjusts Legend Biotech Price Target to $71 From $88, Maintains Buy Rating	MT
07/01/25	RBC Trims Price Target on Legend Biotech to $84 From $86, Keeps Outperform Rating	MT
09/12/24	UBS Lowers Legend Biotech Price Target to $65 From $75, Maintains Buy Rating	MT
08/10/24	Redburn Initiates Legend Biotech at Buy With $86 Price Target	MT
15/07/24	TD Cowen Adjusts Legend Biotech Price Target to $67 From $71, Maintains Buy Rating	MT
17/06/24	Truist Securities Initiates Legend Biotech With Buy Rating, $88 Price Target	MT
24/05/24	HC Wainwright Adjusts Legend Biotech Price Target to $73 From $86, Maintains Buy Rating	MT
24/05/24	Deutsche Bank Starts Legend Biotech With Buy Rating	MT
14/05/24	HC Wainwright Adjusts Price Target on Legend Biotech to $86 From $87, Keeps Buy Rating	MT
14/05/24	RBC Adjusts Price Target on Legend Biotech to $86 From $85 on Model Updates, Maintains Outperform Rating	MT